Systemic Therapies for Advanced Gastrointestinal Carcinoid Tumors-Reference-Cited by-同舟云学术

Systemic Therapies for Advanced Gastrointestinal Carcinoid Tumors

Published:2016-02 Issue:1 Volume:30 Page:63-82
ISSN:0889-8588
Container-title:Hematology/Oncology Clinics of North America
language:en
Short-container-title:Hematology/Oncology Clinics of North America

Author:

Mulvey Claire K.,Bergsland Emily K.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference77 articles.

1. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States;Yao;J Clin Oncol,2008

2. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs);Ramage;Gut,2012

3. Current status of gastrointestinal carcinoids;Modlin;Gastroenterology,2005

4. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas;Reubi;Cancer Res,1990

5. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue;Kvols;N Engl J Med,1986

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Mesenteric Mass in Patients With Midgut Neuroendocrine Tumors;Pancreas;2019-05

2. Carcinoid Heart Disease: Review of Current Knowledge;Texas Heart Institute Journal;2019-02-01

3. Primary hepatic neuroendocrine carcinoma: report of two cases and literature review;BMC Clinical Pathology;2018-03-01

4. Lymph Node Metastasis in the Prognosis of Gastroenteropancreatic Neuroendocrine Tumors;Pancreas;2017-10

5. Long-acting somatostatin analogues in the treatment of unresectable/metastatic neuroendocrine tumors;Seminars in Oncology;2017-04